MenisporphineCAS# 83287-02-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 83287-02-9 | SDF | Download SDF |
PubChem ID | 150032 | Appearance | Powder |
Formula | C19H15NO4 | M.Wt | 321.33 |
Type of Compound | Alkaloids | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
SMILES | COC1=CC2=C(C=C1)C3=NC=CC4=CC(=C(C(=C43)C2=O)OC)OC | ||
Standard InChIKey | LHRMNRPHVHDOJH-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C19H15NO4/c1-22-11-4-5-12-13(9-11)18(21)16-15-10(6-7-20-17(12)15)8-14(23-2)19(16)24-3/h4-9H,1-3H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | 1. Menisporphine shows cytotoxic activity on the target cancer cell lines. 2. Menisporphine shows significant angiogenesis inhibitions. |
Targets | P-gp |
Menisporphine Dilution Calculator
Menisporphine Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 3.1121 mL | 15.5603 mL | 31.1207 mL | 62.2413 mL | 77.8016 mL |
5 mM | 0.6224 mL | 3.1121 mL | 6.2241 mL | 12.4483 mL | 15.5603 mL |
10 mM | 0.3112 mL | 1.556 mL | 3.1121 mL | 6.2241 mL | 7.7802 mL |
50 mM | 0.0622 mL | 0.3112 mL | 0.6224 mL | 1.2448 mL | 1.556 mL |
100 mM | 0.0311 mL | 0.1556 mL | 0.3112 mL | 0.6224 mL | 0.778 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Napabucasin
Catalog No.:BCC6525
CAS No.:83280-65-3
- Lauryl-LF 11
Catalog No.:BCC6175
CAS No.:832729-14-3
- LF 11
Catalog No.:BCC6174
CAS No.:832729-13-2
- APD668
Catalog No.:BCC5389
CAS No.:832714-46-2
- Angelol H
Catalog No.:BCN8047
CAS No.:83247-73-8
- Dehydrocavidine
Catalog No.:BCN2549
CAS No.:83218-34-2
- 1beta-Hydroxy-beta-eudesmol
Catalog No.:BCN7097
CAS No.:83217-89-4
- ISX 9
Catalog No.:BCC6181
CAS No.:832115-62-5
- Astragaloside A
Catalog No.:BCC6494
CAS No.:83207-58-3
- 2',4',6'-Trimethoxyacetophenone
Catalog No.:BCN4847
CAS No.:832-58-6
- Angelol G
Catalog No.:BCN7963
CAS No.:83199-38-6
- 8alpha-Tigloyloxyhirsutinolide 13-O-acetate
Catalog No.:BCN7108
CAS No.:83182-58-5
- 7-Hydroxycoumarin-6-carboxylic acid
Catalog No.:BCN4375
CAS No.:833-52-3
- Bryostatin 1
Catalog No.:BCC7343
CAS No.:83314-01-6
- 8(17),13-Labdadien-15,16-olide
Catalog No.:BCN4374
CAS No.:83324-51-0
- (-)-Lariciresinol
Catalog No.:BCN3418
CAS No.:83327-19-9
- Dynorphin B
Catalog No.:BCC5987
CAS No.:83335-41-5
- 10-O-Caffeoyl-6-epiferetoside
Catalog No.:BCN4822
CAS No.:83348-22-5
- 25(R)-Hydroxyprotopanaxadiol
Catalog No.:BCN2493
CAS No.:83349-37-5
- D609
Catalog No.:BCC1509
CAS No.:83373-60-8
- Prenyl caffeate
Catalog No.:BCC8351
CAS No.:100884-13-7
- PL 017
Catalog No.:BCC5864
CAS No.:83397-56-2
- Phenformin HCl
Catalog No.:BCC4362
CAS No.:834-28-6
- ICI 154,129
Catalog No.:BCC5677
CAS No.:83420-94-4
Aporphine alkaloids and their reversal activity of multidrug resistance (MDR) from the stems and rhizomes of Sinomenium acutum.[Pubmed:16964757]
Arch Pharm Res. 2006 Aug;29(8):627-32.
Chromatographic separation of the MeOH extract from the stems and rhizomes of Sinomemium acutum led to the isolation of nine alkaloids and a lignan. Their structures were determined to be dauriporphine (1), bianfugecine (2), dauriporphinoline (3), Menisporphine (4), (-)-syringaresinol (5), N-feruloyltyramine (6), acutumine (7), dauricumine (8), sinomenine (9), and magnoflorine (10) by spectroscopic means. These compounds were examined for their P-gp mediated MDR reversal activity in human cancer cells. Compound 1 showed the most potent P-gp MDR inhibition activity with an ED50 value 0.03 microg/mL and 0.00010 microg/mL in the MES-SA/DX5 and HCT15 cells, respectively.
New alkaloids and cytotoxic principles from Sinomenium acutum.[Pubmed:23059629]
Planta Med. 2012 Nov;78(17):1873-7.
Two new alkaloids, 2-demethyl-oxypalmatine (1) and 5-ethoxycarbonylsinoracutine (2), were isolated from the rhizomes of Sinomenium acutum, along with thirty-four known compounds. Cytotoxicity of the isolated compounds was examined for the MCF-7, H460, HT-29, and CEM human cancer cell lines. Dauriporphine (16), 6-O-demethylMenisporphine (17), bianfugecine (18), Menisporphine (19), and 6-O-demethyldauriporphine (20) showed differential effects in their cytotoxic activity on the target cancer cell lines. Significant angiogenesis inhibitions of 16 and 19 were also observed.